Analisi facoltativa del prodotto
Con il tuo consenso utilizziamo analisi limitate e rispettose della privacy per capire quali percorsi di ricerca funzionano. Non usiamo tracker pubblicitari né registrazioni delle sessioni. Puoi modificare questa scelta nelle Preferenze. Leggi la Informativa sulla privacy.
Welltower Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $164.9B | |
|---|---|---|
| Revenue (ttm) | 13.8B | |
| Net income (ttm) | 1.7B | |
| EPS (ttm) | $2.32 | |
| Shares out | 733.6M | |
| P/E (trailing) | 97.8x | |
| P/E (forward) | 77.5x | |
| Dividend | $3.40 (1.50%) | |
| Volume | 4,867,974 | |
| Beta | 0.75 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $3.20B | $4.17B | $4.75B | $6.03B | $8.45B | +27.5% |
| Gross profit | $1.93B | $2.22B | $2.53B | $3.02B | $4.18B | +21.2% |
| Operating income | $660.6M | $702.6M | $957.9M | $1.10B | $171.9M | -28.6% |
| Net income | $336.1M | $141.2M | $340.1M | $951.7M | $936.8M | +29.2% |
| EPS (diluted) | $0.78 | $0.30 | $0.66 | $1.57 | $1.39 | +15.5% |
| EBITDA | $1.71B | $2.04B | $2.40B | $2.78B | $2.31B | +7.8% |
| R&D | $0 | $0 | $0 | — | — | +11.8% |
| SG&A | $126.7M | $150.4M | $179.1M | $235.5M | $1.75B | +92.7% |
Recent company headlines from major financial publishers.
The base path projects steady occupancy recovery across senior housing facilities, with annual resident rate increases offsetting labor expenses. Contractual rental income from triple-net and outpatient properties provides cash flow stability, leading to an intrinsic target of $73.89 representing an expected return of -68.3% with probability 60.0%.
The bull path envisions accelerating senior housing occupancy exceeding pre-pandemic peaks, coupled with double-digit RevPOR growth that drives operating margins above historical norms. Capital deployment via accretive acquisitions further enhances cash generation, yielding an intrinsic target of $82.97 and an expected return of -64.4% with probability 20.0%.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 6.1% | $111 | $113 | $116 | $120 | $125 |
| 7.1% | $87.4 | $88.9 | $90.6 | $92.8 | $95.6 |
| 8.1% | $71.8 | $72.7 | $73.9 | $75.3 | $77.0 |
| 9.1% | $61.3 | $62.0 | $62.8 | $63.7 | $64.9 |
| 10.1% | $53.3 | $53.8 | $54.4 | $55.1 | $55.9 |
Upcoming earnings date and setup when available.
Il rating riportato dall'edizione di ricerca pubblicata ogni mese. Un rating confronta il prezzo alla data dell'analisi con il valore equo; non indica se la valutazione si è rivelata corretta.
| Anno | gen | feb | mar | apr | mag | giu | lug | ago | set | ott | nov | dic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
